These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6320036)

  • 1. Pharmacological profile of the antidepressant adinazolam, a triazolobenzodiazepine.
    Lahti RA; Sethy VH; Barsuhn C; Hester JB
    Neuropharmacology; 1983 Nov; 22(11):1277-82. PubMed ID: 6320036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitization of rat forebrain neurons to serotonin by adinazolam, an antidepressant triazolobenzodiazepine.
    Turmel A; De Montigny C
    Eur J Pharmacol; 1984 Mar; 99(2-3):241-4. PubMed ID: 6734729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. U-43,465F: a triazolobenzodiazepine with pronounced antidepressant-like as well as anxiolytic activities in animals.
    Von Voigtlander PF; Puech AJ
    Arch Int Pharmacodyn Ther; 1983 Nov; 266(1):60-76. PubMed ID: 6141773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adinazolam affects biogenic amine release in hippocampal CA1 neuronal circuitry.
    Broderick PA
    Brain Res Bull; 1991 Nov; 27(5):689-92. PubMed ID: 1756387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of adinazolam on plasma catecholamine, heart rate and blood pressure responses in stressed and non-stressed rats.
    Krieman MJ; Hershock DM; Greenberg IJ; Vogel WH
    Neuropharmacology; 1992 Jan; 31(1):33-8. PubMed ID: 1542400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain.
    Owens MJ; Bissette G; Nemeroff CB
    Synapse; 1989; 4(3):196-202. PubMed ID: 2575286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic antidepressant and benzodiazepine treatment on corticotropin-releasing-factor receptors in rat brain and pituitary.
    Grigoriadis DE; Pearsall D; De Souza EB
    Neuropsychopharmacology; 1989 Mar; 2(1):53-60. PubMed ID: 2553044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adinazolam, a new triazolobenzodiazepine, and imipramine in the treatment of major depressive disorder.
    Amsterdam JD; Kaplan M; Potter L; Bloom L; Rickels K
    Psychopharmacology (Berl); 1986; 88(4):484-8. PubMed ID: 3085137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of triazolo-benzodiazepine and benzodiazepine action in anxiety and depression: behavioral studies with concomitant in vivo CA1 hippocampal norepinephrine and serotonin release detection in the behaving animal.
    Broderick PA; Hope O; Jeannot P
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Feb; 22(2):353-86. PubMed ID: 9608607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of triazolobenzodiazepines in two animal tests of anxiety and in the holeboard.
    File SE; Pellow S
    Br J Pharmacol; 1985 Nov; 86(3):729-35. PubMed ID: 2866006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ranitidine does not alter adinazolam pharmacokinetics or pharmacodynamics.
    Suttle AB; Songer SS; Dukes GE; Hak LJ; Koruda M; Fleishaker JC; Brouwer KL
    J Clin Psychopharmacol; 1992 Aug; 12(4):282-7. PubMed ID: 1527233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant properties of the triazolobenzodiazepines alprazolam and adinazolam: studies on the olfactory bulbectomized rat model of depression.
    O'Connor WT; Earley B; Leonard BE
    Br J Clin Pharmacol; 1985; 19 Suppl 1():49S-56S. PubMed ID: 2859878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of serotonin type 2 (5-HT2) and beta-adrenergic receptors in rat cerebral cortex following novel and classical antidepressant treatment.
    Lafaille F; Welner SA; Suranyi-Cadotte BE
    J Psychiatry Neurosci; 1991 Nov; 16(4):209-14. PubMed ID: 1664741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. U 43,465F: a benzodiazepine with antidepressant activity? Interaction with Ro 15-1788 and d,1-propranolol.
    Thiebot MH; Doare L; Puech AJ; Simon P
    Eur J Pharmacol; 1982 Oct; 84(1-2):103-6. PubMed ID: 6128234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and pharmacological evaluation of the novel antidepressant and serotonin uptake inhibitor 2-(3,4-Dichlorobenzyl)-2-dimethylamino-1-propanol hydrochloride.
    Gouret CJ; Porsolt R; Wettstein JG; Puech A; Soulard C; Pascaud X; Junien JL
    Arzneimittelforschung; 1990 Jun; 40(6):633-40. PubMed ID: 2168703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacology of adinazolam and N-desmethyladinazolam mesylate after single oral doses of each compound in healthy volunteers.
    Fleishaker JC; Friedman H; Pollock SR; Smith TC
    Clin Pharmacol Ther; 1990 Dec; 48(6):652-64. PubMed ID: 2249377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of antidepressants on L-5HTP-induced changes in rat plasma corticosteroids.
    Lahti RA; Barsuhn C
    Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):343-9. PubMed ID: 6967219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adinazolam both prevents and reverses the long-term reduction of daily activity produced by inescapable shock.
    Maier SF; Silbert LH; Woodmansee WW; Desan PH
    Pharmacol Biochem Behav; 1990 Aug; 36(4):767-73. PubMed ID: 2217504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triazolobenzodiazepines antagonize the effects of anxiogenic drugs mediated at three different central nervous system sites.
    File SE; Pellow S
    Neurosci Lett; 1985 Oct; 61(1-2):115-9. PubMed ID: 2867497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of adinazolam, amitriptyline, and diazepam in endogenous depressive inpatients exhibiting DST nonsuppression or abnormal contingent negative variation.
    Ansseau M; Devoitille JM; Papart P; Vanbrabant E; Mantanus H; Timsit-Berthier M
    J Clin Psychopharmacol; 1991 Jun; 11(3):160-5. PubMed ID: 2066454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.